The ₹650 crore Tempsens Instruments IPO has achieved a remarkable 62.23 times subscription as of 11:27 AM on Monday, August 24, with the final day of bidding showing exceptional investor demand. The strong performance represents a significant increase from earlier reported figures, with retail investors showing particularly strong interest at 39.18 times subscription against the 75.65 lakh shares reserved for the segment. The non-institutional investor (NII) portion led the demand with 186.37 times subscription, while the qualified institutional buyer (QIB) portion was booked 9.32 times. The employee reserved portion also showed robust participation at 35.89 times subscription. The three-day IPO, which opened for bidding on August 20, 2026, received bids for 94.48 crore shares against 1.51 crore shares on offer as of the latest data. The IPO allotment is expected to be finalised on August 25, 2026, with the company scheduled to list on both NSE and BSE on August 28.
Tempsens Instruments' grey market premium has surged to ₹318 as of 9:30 AM on the final day, marking a significant increase from earlier reported figures and indicating strong investor confidence. This represents a substantial increase from earlier reported figures, indicating strong investor confidence and reviving appetite for new share sales after a string of muted mainboard listings in 2025 and 2026. The GMP of ₹318 as of August 24 indicates an estimated listing price of around ₹618 per share (cap price of ₹300 + GMP of ₹318), translating to a potential premium of nearly 106% over the issue price. The last IPO to record a GMP of more than 100% was Mamata Machinery in December 2024, with KRN Heat Exchanger and Refrigeration and Bajaj Housing Finance having seen GMPs of around 100% in September 2024. The Tempsens Instruments IPO has set its price band at ₹285-₹300 per share with a lot size of 50 shares, requiring a minimum investment of ₹15,000 at the upper price band.
Multiple brokerage firms have issued positive recommendations for the Tempsens Instruments IPO, with Anand Rathi assigning a 'Subscribe - Long Term' rating despite the issue appearing fully valued at the upper price band. As per The Economic Times, Anand Rathi states that at an implied P/E of 35.4x and EV/EBITDA of 25.64x on FY26 earnings, the company may command a valuation premium given its strong revenue growth, diversified product portfolio and expanding international presence. KC Securities has assigned a 'Subscribe' tag, noting that at the upper price band of ₹300, the issue is valued at 37.3x FY26 P/E, which is at a premium but justified by superior growth and niche positioning. Adroit Financial Services, Ajcon Global Services, Arihant Capital Markets, BP Equities, Canara Bank Securities, Geojit Investments, GEPL Capital, Marwadi Shares & Finance, Swastika Investmart, and Ventura Securities have also recommended subscribing to the IPO. As per SBI Securities, this performance is anchored by expanding high-margin international operations and a loyal, long-term customer base.
Ahead of the IPO, Tempsens Instruments raised ₹194.54 crore from anchor investors on August 19, with the company allotting 64.84 lakh shares at ₹300 apiece to 29 anchor investors. The anchor book saw participation from several prominent institutional investors, including Aranda Investments, owned by Singapore's Temasek Holdings, Goldman Sachs and Prashant Khemka's Ashoka WhiteOak ICAV - Ashoka WhiteOak Emerging Markets Equity Fund. Of the total anchor allocation, 37.21 lakh shares were allotted to eight domestic mutual funds including HDFC AMC, Nippon Life India, Kotak Mahindra AMC, Aditya Birla Sun Life AMC, Edelweiss and Tata Mutual Fund through 14 schemes. The Tempsens Instruments IPO comprises a fresh issue of ₹95 crore and an offer for sale (OFS) of 1.85 crore shares aggregating ₹555 crore by existing shareholders including Amit Talesara, Puneet Talesara and Chandra Prakash Talesara.
Tempsens Instruments demonstrated robust financial growth with Total Income jumping 19% to ₹455.86 crore in FY26 from ₹382.47 crore in FY25. The company's Profit After Tax (PAT) grew 14% to ₹71.07 crore in FY26 from ₹62.56 crore in FY25. The IPO proceeds will be used for capital expenditure to scale up electrical heating solutions and specialised cable manufacturing capabilities, along with full or partial prepayment of outstanding corporate borrowings and general corporate purposes. ₹18.13 crore from the net proceeds of the fresh issue will be allocated for capital expenditure towards electrical heating solutions and specialised cable solutions businesses, while ₹55 crore has been earmarked for debt repayment. The balance proceeds will be deployed for general corporate purposes, providing the company with flexibility to address broader operational and business needs. ₹73.13 crore of the net proceeds from the fresh issue will fund expansion initiatives and improve the company's financial position.
Tempsens Instruments (India) Ltd., established in 1990, manufactures temperature sensors, electrical heating solutions and specialised cables with a product portfolio including both contact and non-contact temperature-sensing solutions. According to the F&S report cited in the IPO documents, the company was India's largest manufacturer of contact and non-contact temperature sensors by revenue as of March 31, 2026, with an estimated 10.5% share of the temperature sensor market. The company is also the only Indian manufacturer of non-contact temperature sensors, with an estimated 21.3% share of the segment in FY26. Between April 1, 2023 and March 31, 2026, Tempsens Instruments served more than 1,000 unique customers and exports its products to more than 80 countries, including the UAE, Germany and Poland. The company's global presence spans markets across Asia Pacific, Africa and the Middle East, North Africa, Europe, and North and South America, with 71.5% of FY26 revenue generated from domestic business and 28.5% from exports. The GMP strength indicates market sentiment towards the IPO based on demand-supply dynamics, with GMPs for several other upcoming IPOs also strengthening, including Lumino Industries at 62% GMP, Augmont Enterprises and Hy-Tech Engineers at around 50% premiums, suggesting investor appetite for new share sales appears to be reviving.
